Immunotherapy Biosimilar

Samsung Bioepis,Immunotherapy Biosimilar,Keytruda,Vision,Challenges

Pioneering the Future of Cancer Treatment: Samsung Bioepis Accelerates Development of Keytruda Biosimilar

SOUTH KOREA 4월 7, 2024 • 0 Comment
[su_heading size=”27″ align=”left” margin=”40″]Samsung Bioepis Leads the Race in Developing World’s Top Immunotherapy Biosimilar[/su_heading] In the high-stakes world of biopharmaceuticals,…